Date of Original Release:
December 1, 2022. Date of most recent review: November 10, 2022. Termination date: December 1, 2025.
EB Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
EB Medicine designates this enduring material for a maximum of 4 AMA PRA Category 1 CreditsTM
. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Included as part of the 4 credits, this CME activity is eligible for 2 Pharmacology CME credits, subject to your state and institutional approval.
AOA Accreditation: Evidence-Based Urgent Care
is eligible for 4 Category 2-A or 2-B credit hours per issue by the American Osteopathic Association.
The need for this educational activity was determined by a practice gap analysis; a survey of medical staff; review of morbidity and mortality data from the CDC, AHA, NCHS, and ACEP; and evaluation responses from prior educational activities for urgent care and emergency medicine physicians.
This internet enduring material is designed for physicians, physician assistants, nurse practitioners, and residents in the urgent care and family practice settings.
Upon completion of this activity, you should be able to: (1) identify areas in practice that require modification to be consistent with current evidence in order to improve competence and performance; (2) develop strategies to accurately diagnose and treat both common and critical urgent care presentations; and (3) demonstrate informed medical decision-making based on the strongest clinical evidence.
Upon completion of this activity, you should be able to: (1) discuss the epidemiology and spread of the strains and subtypes of influenza; (2) describe when to consider antiviral drug treatment for influenza based on clinical presentation alone and when more formal testing is indicated; (3) list the factors that place a patient at higher risk for a more severe disease course; and (4) identify the antiviral agents available for influenza, their pharmacologic effects, and how to select the best agent for a particular patient in a particular location.
Discussion of Investigational Information:
As part of the activity, faculty may be presenting investigational information about pharmaceutical products that is outside Food and Drug Administration approved labeling. Information presented as part of this activity is intended solely as continuing medical education and is not intended to promote off-label use of any pharmaceutical product.
It is the policy of EB Medicine to ensure objectivity, balance, independence, transparency, and scientific rigor in all CME activities. All individuals in a position to control content have disclosed all financial relationships with ACCME-defined ineligible companies. EB Medicine has assessed all relationships with ineligible companies disclosed, identified those financial relationships deemed relevant, and appropriately mitigated all relevant financial relationships based on each individual’s role(s). Please find disclosure information for this activity below:
Keith Pochick, MD (Editor-in-Chief): Nothing to Disclose
Joshua Russell, MD, MSc (Author): Nothing to Disclose
Michael Kim, DO (Peer Reviewer): Nothing to Disclose
Huai Lee Phen, MD (Peer Reviewer): Nothing to Disclose
Bradley Laymon, PA-C (Charting Tips Author): Nothing to Disclose
Angie Wallace (Content Editor): Nothing to Disclose
This issue of Evidence-Based Urgent Care
did not receive any commercial support.
Go online to www.ebmedicine.net/CME
and click on the title of the test you wish to take.When completed, a CME certificate will be emailed to you.
For additional policies, including our statement of conflict of interest, source of funding, statement of informed consent, and statement of human and animal rights, visit www.ebmedicine.net/policies